Through the use of human melanoma cell lines [96], lung cancer [97], and triple-negative breast cancer [98], the antimetastatic or anti-invasive action of berberine has been analyzed through the inhibition of signaling pathways such as MAPK or the deregulation or inhibition of TGF-β production. This evidence concerns the gene TGFB1 and lung cancer.